Forex Education Symbols

25.5 0 (0%) 02-16 16:30
Open: 25.15 Prev Close: 25.5
High: 25.73 Low: 25.15
Volume: 63,063 Market Cap: 152M
Year High: 39.5 Year Low: 23
Stock Technical Analysis
Targets Six months: 34.25    One year: 37.38
Supports Support1: 25.00   Support2: 20.80
Resistances Resistance1: 29.33    Resistance2: 32.00 
Pivot Point 27.69 
Moving Averages MA(5): 26.05      MA(20): 28.22 

MA(100): 30.91      MA(250): 29.095 
MACD MACD(12,26): -1.01      Signal(12,26,9): -0.67 
Stochastic Oscillator %K(14,3): 9.58      %D(3): 12.49 
RSI RSI(14): 17.84 
52-Week High: 39.50  Low: 23.00  Change(%):
Average Volume(K) 3-Month: 13366  10-Days: 11333.240234
Moving Averages analysis
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
Bollinger Bands Analysis
AGY.L has closed above bottom band by 13.0%. Bollinger Bands are 35.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
Stock News
Allergy Therapeutics' grass pollen study running ahead of schedule
Mon, 12 Feb 2018 07:27:10 GMT

Allergy Therapeutics plc (AIM:AGY): Is Now The Time To Bet On Healthcare?
Mon, 20 Nov 2017 17:15:00 GMT

Allergy Therapeutics PLC
Wed, 06 Sep 2017 11:43:42 GMT

Allergy Therapeutics PLC Announces Novel House Dust Mite Allergy Vaccine Gains ...
Tue, 14 Feb 2017 06:56:15 GMT

Allergy Therapeutics completes recruitment for phase III birch pollen trial
Tue, 09 Jan 2018 08:42:38 GMT

Allergy Therapeutics expects first-half revenue rise; continues to take market ...
Wed, 31 Jan 2018 08:03:45 GMT

Stoxline Canada

Stock Chart London

Option Calculator

EPS Est. Current Year
EPS Est. Next Year
EPS Est. Next Quarter
Forward EPS
Shares Out. (M)
Shares Float (M) 1.27
Book Value (p.s.)
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm)
Return on Equity (ttm)
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth
Operating Cash Flow (M)
Levered Free Cash Flow (M)
P/E 0.40
P/E Growth Ratio